Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2004 Jun;59(6):522–525. doi: 10.1136/thx.2003.016105

Clinical features, aetiology and outcome of empyema in children in the north east of England

K Eastham 1, R Freeman 1, A Kearns 1, G Eltringham 1, J Clark 1, J Leeming 1, D Spencer 1
PMCID: PMC1747032  PMID: 15170039

Abstract

Background: The incidence of empyema in children in the UK is increasing. The reason for this is unclear. A prospective study was undertaken to investigate the clinical features, aetiology, and outcome of cases of empyema and parapneumonic effusion presenting to a tertiary paediatric respiratory centre between February 1997 and August 2001.

Method: Routine bacterial culture of blood and pleural fluid was performed for 47 cases. Forty three pleural fluid specimens, culture negative for pneumococcus, were analysed for pneumococccal DNA by real time polymerase chain reaction (PCR). Penicillin susceptibility was determined for DNA positive specimens using complementary PCR assay. Capsular serotype specific antigen detection was by enzyme immunoassay (EIA) using monoclonal antibodies to serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F. Clinical data were obtained from patient notes, supplemented by a postal questionnaire.

Results: The median (range) age of the patients was 5.6 (0.6–16.9) years and 70% were male. The median (range) duration of illness before referral to hospital was 5 (0–25) days. Forty five (96%) had received antibiotics before referral; 32 (68%) required decortication and eight (21%) thoracocentesis. Median postoperative stay was 4 days (2–8). Thirty two (75%) pneumococcal culture negative specimens were pneumococcal DNA positive; 17 (53%) of these were serotype 1. All were penicillin sensitive.

Conclusions: Pneumococcus is the major pathogen in childhood empyema and serotype 1 is the prevalent serotype. This has implications for vaccine development and immunisation strategy as the current 7-valent pneumococcal conjugate vaccine does not protect against serotype 1.

Full Text

The Full Text of this article is available as a PDF (103.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buckingham Steven C., King Michaela D., Miller Martha L. Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001. Pediatr Infect Dis J. 2003 Jun;22(6):499–504. doi: 10.1097/01.inf.0000069764.41163.8f. [DOI] [PubMed] [Google Scholar]
  2. Byington Carrie L., Spencer LaShonda Y., Johnson Timothy A., Pavia Andrew T., Allen Daniel, Mason Edward O., Kaplan Sheldon, Carroll Karen C., Daly Judy A., Christenson John C. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis. 2002 Jan 3;34(4):434–440. doi: 10.1086/338460. [DOI] [PubMed] [Google Scholar]
  3. Carey J. A., Hamilton J. R., Spencer D. A., Gould K., Hasan A. Empyema thoracis: a role for open thoracotomy and decortication. Arch Dis Child. 1998 Dec;79(6):510–513. doi: 10.1136/adc.79.6.510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dagan R., Gradstein S., Belmaker I., Porat N., Siton Y., Weber G., Janco J., Yagupsky P. An outbreak of Streptococcus pneumoniae serotype 1 in a closed community in southern Israel. Clin Infect Dis. 2000 Feb;30(2):319–321. doi: 10.1086/313645. [DOI] [PubMed] [Google Scholar]
  5. Finland M., Barnes M. W. Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974. J Clin Microbiol. 1977 Feb;5(2):154–166. doi: 10.1128/jcm.5.2.154-166.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Finn A., Booy R., Moxon R., Sharland M., Heath P. Should the new pneumococcal vaccine be used in high-risk children? Arch Dis Child. 2002 Jul;87(1):18–21. doi: 10.1136/adc.87.1.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Greenwood B. M., Hassan-King M., Onyemelukwe G., Macfarlane J. T., Tubbs H. R., Tugwell P. J., Whittle H. C., Denis F., Chiron J. P., M'boup S. Pneumococcal serotypes in West Africa. Lancet. 1980 Feb 16;1(8164):360–360. doi: 10.1016/s0140-6736(80)90900-9. [DOI] [PubMed] [Google Scholar]
  8. Henriques Normark B., Kalin M., Ortqvist A., Akerlund T., Liljequist B. O., Hedlund J., Svenson S. B., Zhou J., Spratt B. G., Normark S. Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. J Infect Dis. 2001 Aug 27;184(7):861–869. doi: 10.1086/323339. [DOI] [PubMed] [Google Scholar]
  9. Kearns Angela M., Graham Clive, Burdess Doreen, Heatherington Jane, Freeman Roger. Rapid real-time PCR for determination of penicillin susceptibility in pneumococcal meningitis, including culture-negative cases. J Clin Microbiol. 2002 Feb;40(2):682–684. doi: 10.1128/JCM.40.2.682-684.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Light R. W. A new classification of parapneumonic effusions and empyema. Chest. 1995 Aug;108(2):299–301. doi: 10.1378/chest.108.2.299. [DOI] [PubMed] [Google Scholar]
  11. McIntosh E. David G., Conway Peter, Willingham Julie, Lloyd Adam. The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine. Vaccine. 2003 Jun 2;21(19-20):2564–2572. doi: 10.1016/s0264-410x(03)00031-8. [DOI] [PubMed] [Google Scholar]
  12. Miller E., Waight P., Efstratiou A., Brisson M., Johnson A., George R. Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998. Acta Paediatr Suppl. 2000 Dec;89(435):11–16. doi: 10.1111/j.1651-2227.2000.tb00776.x. [DOI] [PubMed] [Google Scholar]
  13. Playfor S. D., Smyth A. R., Stewart R. J. Increase in incidence of childhood empyema. Thorax. 1997 Oct;52(10):932–932. [PubMed] [Google Scholar]
  14. Rees J. H., Spencer D. A., Parikh D., Weller P. Increase in incidence of childhood empyema in West Midlands, UK. Lancet. 1997 Feb 8;349(9049):402–402. doi: 10.1016/s0140-6736(97)80022-0. [DOI] [PubMed] [Google Scholar]
  15. Rosenthal M., Bain S. H., Cramer D., Helms P., Denison D., Bush A., Warner J. O. Lung function in white children aged 4 to 19 years: I--Spirometry. Thorax. 1993 Aug;48(8):794–802. doi: 10.1136/thx.48.8.794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Tan Tina Q., Mason Edward O., Jr, Wald Ellen R., Barson William J., Schutze Gordon E., Bradley John S., Givner Laurence B., Yogev Ram, Kim Kwang Sik, Kaplan Sheldon L. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics. 2002 Jul;110(1 Pt 1):1–6. doi: 10.1542/peds.110.1.1. [DOI] [PubMed] [Google Scholar]
  17. Tuomanen E., Durack D. T., Tomasz A. Antibiotic tolerance among clinical isolates of bacteria. Antimicrob Agents Chemother. 1986 Oct;30(4):521–527. doi: 10.1128/aac.30.4.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Watson D. A., Musher D. M., Verhoef J. Pneumococcal virulence factors and host immune responses to them. Eur J Clin Microbiol Infect Dis. 1995 Jun;14(6):479–490. doi: 10.1007/BF02113425. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES